Table 6.
Analysis of the coagulation of male and female cat blood fed AFD1 (mean ± SD).
Study day | AFD1 level | Reference ranges | ||||
---|---|---|---|---|---|---|
0 ppm | 7 ppm | 39 ppm | 66 ppm | |||
Males | ||||||
APTT (s) |
−7 | 11.84 ± 1.12 | 11.86 ± 0.92 | 12.14 ± 0.87 | 11.28 ± 0.77 | 11.2–16.0# |
100 | 12.48 ± 1.56 | 11.74 ± 0.82 | 12.00 ± 0.97 | 11.66 ± 0.73 | ||
182 | 11.88 ± 0.49 | 12.36 ± 0.63 | 12.02 ± 0.56 | 11.96 ± 0.55 | ||
PT (s) |
−7 | 11.14 ± 0.47 | 11.06 ± 0.57 | 11.48 ± 0.54 | 11.52 ± 0.52 | 10.0–15.3# |
100 | 12.18 ± 0.68 | 11.46 ± 0.83 | 12.00 ± 0.73 | 11.34 ± 0.56 | ||
182 | 11.18 ± 0.29 | 11.24 ± 0.70 | 11.48 ± 0.36 | 11.46 ± 0.63 | ||
TT (s) |
−7 | 16.20 ± 0.92 | 16.62 ± 0.57 | 15.66 ± 0.52 | 16.46 ± 1.01 | 13.4–19.1## |
100 | 15.76 ± 0.80 | 17.30**± 1.02 | 17.42**± 0.93 | 17.44**± 0.56 | ||
182 | 17.26 ± 1.23 | 17.46 ± 0.68 | 17.06 ± 0.98 | 17.42 ± 0.99 | ||
Females | ||||||
APTT (s) |
−7 | 11.70 ± 1.38 | 11.72 ± 0.71 | 11.56 ± 0.68 | 11.94 ± 0.67 | 11.2–16.0# |
100 | 13.76 ± 1.23 | 12.16**± 0.52 | 11.70**± 0.41 | 12.40**± 0.92 | ||
182 | 12.38 ± 0.24 | 12.48 ± 0.75 | 12.24 ± 0.18 | 12.22 ± 1.01 | ||
PT (s) |
−7 | 12.26 ± 0.82 | 12.20 ± 1.75 | 11.76 ± 0.71 | 12.08 ± 0.75 | 10.0–15.3# |
100 | 13.08 ± 0.36 | 11.86*± 0.61 | 12.32*± 0.76 | 12.24*± 0.87 | ||
182 | 11.78 ± 0.89 | 12.04 ± 0.62 | 12.08 ± 0.41 | 11.94 ± 0.87 | ||
TT (s) |
−7 | 16.66 ± 1.34 | 17.22 ± 1.36 | 15.92 ± 1.08 | 15.68 ± 0.61 | 13.4–19.1## |
100 | 16.06 ± 0.70 | 18.26*± 0.83 | 16.36 ± 0.63 | 16.30*± 0.99 | ||
182 | 18.12 ± 0.70 | 17.84*± 0.67 | 16.82*± 0.44 | 16.56**± 0.59 |
AFD1, anti-Fel d 1 IgY; APTT, Activated Partial Thromboplastin Time; PT, Prothrombin Time; TT, Thrombin Time.
Significant at P < 0.05 when compared to the control group within a study day;
Significant at P < 0.01 when compared to the control group within a study day;
UC Davis (21);
Engelen et al. (22).
SD, Standard deviation.